Bayer attempts to block Watson, Sandoz versions of Yasmin

04/22/2008 | Forbes · Bloomberg

Bayer AG has filed a patent-infringement suit against Watson Pharmaceuticals and Sandoz, a subsidiary of Novartis AG, over generic versions of Yasmin, its oral contraceptive. The lawsuit prevents Sandoz and Watson from obtaining U.S. marketing clearance for their copies of the drug for as long as 30 months or until the dispute is settled, Watson said in a statement.

View Full Article in:

Forbes · Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC